Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
China flag China · Delayed Price · Currency is CNY
20.80
+0.41 (2.01%)
Last updated: Jul 14, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Antivenom
155.87M
Log In
Log In
Log In
Log In
Upgrade
Antivenom Growth
11.31%
Log In
Log In
Log In
Log In
Upgrade
Equine Tetanus Immunoglobulin
34.27M
Log In
Log In
Log In
Log In
Upgrade
Equine Tetanus Immunoglobulin Growth
0.26%
Log In
Log In
Log In
Log In
Upgrade
Other Business
-
Log In
Log In
Log In
Log In
Upgrade
Other Business Growth
-
Log In
Log In
Log In
Log In
Upgrade
Anti-Pit Viper Venom Serum
-
Log In
Log In
Log In
Log In
Upgrade
Anti-Pit Viper Venom Serum Growth
-
Log In
Log In
Log In
Log In
Upgrade
Anti-Five-Step Snake Venom Serum
-
Log In
Log In
Log In
Log In
Upgrade
Anti-Five-Step Snake Venom Serum Growth
-
Log In
Log In
Log In
Log In
Upgrade
Anticobra Venom Serum
-
Log In
Log In
Log In
Log In
Upgrade
Anticobra Venom Serum Growth
-
Log In
Log In
Log In
Log In
Upgrade
Anti-Bungaro Venom Serum
-
Log In
Log In
Log In
Log In
Upgrade
Anti-Bungaro Venom Serum Growth
-
Log In
Log In
Log In
Log In
Upgrade
Anti-Rabies Serum
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
China
188.78M
Log In
Log In
Log In
Log In
Upgrade
China Growth
9.20%
Log In
Log In
Log In
Log In
Upgrade
Overseas
1.37M
Log In
Log In
Log In
Log In
Upgrade
Overseas Growth
1.94%
Log In
Log In
Log In
Log In
Upgrade